People: Concert Pharmaceuticals Inc (CNCE.OQ)
18 Apr 2019
Ms. Nancy Stuart is the Chief Operating Officer of Concert Pharmaceuticals Inc. Ms. Stuart has over 20 years of biotechnology and pharmaceutical industry experience. Prior to joining Concert, Ms. Stuart held various business operations and business development positions at Amgen Inc., a biopharmaceutical company, Kinetix Pharmaceuticals, Inc., a pharmaceutical company subsequently acquired by Amgen, Scion Pharmaceuticals, Inc., a pharmaceutical company, Vertex and Genzyme Corporation, a biotechnology company subsequently acquired by Sanofi S.A. Ms. Stuart holds a B.S. from the University of Michigan, and an M.B.A. from the Simmons College Graduate School of Management.
|Total Annual Compensation, USD||398,247|
|Restricted Stock Award, USD||832,200|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||716,854|
|Fiscal Year Total, USD||1,947,300|